5-alpha-reductase inhibitors are associated with reduced frequency of COVID-19 symptoms in males with androgenetic alopecia

J Eur Acad Dermatol Venereol. 2021 Apr;35(4):e243-e246. doi: 10.1111/jdv.17021. Epub 2020 Nov 22.
No abstract available

Publication types

  • Letter

MeSH terms

  • 5-alpha Reductase Inhibitors / therapeutic use*
  • Adult
  • Alopecia / complications
  • Alopecia / drug therapy*
  • COVID-19 / complications*
  • COVID-19 / diagnosis
  • COVID-19 / therapy
  • Humans
  • Male
  • Middle Aged
  • Retrospective Studies
  • Symptom Assessment

Substances

  • 5-alpha Reductase Inhibitors